20-CARBOXY-23-HYDROXY-11-OXO-30-NOROLEAN-12-EN-3-YL 2-O-.BETA.-D-GLUCOPYRANURONOSYL-.ALPHA.-D-GLUCOPYRANOSIDURONIC ACID, (3.BETA.,4.BETA.,20.BETA.)-
UNII ERB4JS2WQJ

Substance Identification & Data

This profile provides standardized clinical and technical data for 20-carboxy-23-hydroxy-11-oxo-30-norolean-12-en-3-yl 2-o-.beta.-d-glucopyranuronosyl-.alpha.-d-glucopyranosiduronic Acid, (3.beta.,4.beta.,20.beta.)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) ERB4JS2WQJ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 215720-45-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
ERB4JS2WQJ
CAS Registry Number
215720-45-9
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
20-CARBOXY-23-HYDROXY-11-OXO-30-NOROLEAN-12-EN-3-YL 2-O-.BETA.-D-GLUCOPYRANURONOSYL-.ALPHA.-D-GLUCOPYRANOSIDURONIC ACID, (3.BETA.,4.BETA.,20.BETA.)-
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C42H62O17
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
WBQVRPYEEYUEBQ-TYGSXCDJSA-N
Line notation for describing the chemical structure and connectivity of atoms.
PubChem CID
Unique identification number in the NCBI database of chemical substances.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
[C@@]1(CC[C@]2([C@@](C1)(C=3[C@@]([C@]4([C@@]([C@@]5([C@]([C@]([C@H](CC5)O[C@@]6([C@@H]([C@H]([C@@H]([C@H](O6)C(=O)O)O)O)O[C@@]7([C@@H]([C@H]([C@@H]([C@H](O7)C(O)=O)O)O)O)[H])[H])(CO)C)(CC4)[H])C)(C(C3)=O)[H])C)(CC2)C)[H])C)(C)C(O)=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for 20-carboxy-23-hydroxy-11-oxo-30-norolean-12-en-3-yl 2-o-.beta.-d-glucopyranuronosyl-.alpha.-d-glucopyranosiduronic Acid, (3.beta.,4.beta.,20.beta.)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

(3.BETA.,4.BETA.,20.BETA.)-20-CARBOXY-23-HYDROXY-11-OXO-30-NOROLEAN-12-EN-3-YL 2-O-.BETA.-D-GLUCOPYRANURONOSYL-.ALPHA.-D-GLUCOPYRANOSIDURONIC ACID
.ALPHA.-D-GLUCOPYRANOSIDURONIC ACID, (3.BETA.,4.BETA.,20.BETA.)-20-CARBOXY-23-HYDROXY-11-OXO-30-NOROLEAN-12-EN-3-YL 2-O-.BETA.-D-GLUCOPYRANURONOSYL-
AMMONIUM GLYCYRRHIZATE IMPURITY A [EP IMPURITY]

Systematic Nomenclature

(2S,3S,4S,5R,6R)-6-((2S,3R,4S,5S,6S)-2-(((3S,4S,4AR,6AR,6BS,8AS,11S,12AR,14AR,14BS)-11-CARBOXY-4-(HYDROXYMETHYL)-4,6A,6B,8A,11,14B-HEXAMETHYL-14-OXO-2,3,4A,5,6,7,8,9,10,12,12A,14A-DODECAHYDRO-1H-PICEN-3-YL)OXY)-6-CARBOXY-4,5-DIHYDROXYOXAN-3-YL)OXY-3,4,5-TRIHYDROXYOXANE-2-CARBOXYLIC ACID
20-CARBOXY-23-HYDROXY-11-OXO-30-NOROLEAN-12-EN-3-YL 2-O-.BETA.-D-GLUCOPYRANURONOSYL-.ALPHA.-D-GLUCOPYRANOSIDURONIC ACID, (3.BETA.,4.BETA.,20.BETA.)-